PSTV- Plus Therapeutics, Inc.

Name: Plus Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Plus Therapeutics, Inc. (PSTV) has 7 insiders with recent SEC Form 4 filings, including 13 buys and 1 sell. PSTV is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Hawkins Richard J	397.8K	$2.43M	-
CEO	Hedrick Marc H	339.8K	$2.08M	-
Dir	Van Es-Johansson An	297.8K	$1.82M	-
Dir	Clowes Howard	297.8K	$1.82M	-
Dir	Guse Kyle	297.8K	$1.82M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 8, 2024	Clowes Howard	Director	Buy	9,804	$2.04	$20,000.16	+83.8%	-29.5%	-72.7%
May 8, 2024	Hawkins Richard J	Director	Buy	4,902	$2.04	$10,000.08	+490,200%	-29.5%	-72.7%
May 8, 2024	Lenk Robert P50	Director	Buy	4,167	$2.04	$8,500.68	+16.6%	-29.5%	-72.7%
May 8, 2024	Petersen Greg	Director	Buy	12,255	$2.04	$25,000.20	+50.7%	-29.5%	-72.7%
Nov 20, 2023	Hedrick Marc H	Chief Executive Officer	Sell	2,068	$1.96	$4,052.66	-92.4%	+5.8%	-34.7%
Nov 16, 2023	Lenk Robert P50	Director	Buy	2,000	$1.86	$3,720.00	+4.2%	-11.0%	-46.3%
Nov 13, 2023	Lenk Robert P50	Director	Buy	6,000	$1.44	$8,620.00	+16.5%	+33.6%	-11.6%
Nov 9, 2023	Lenk Robert P50	Director	Buy	9,199	$1.62	$14,926.41	+44.0%	+29.3%	-18.0%
Nov 7, 2023	Lenk Robert P50	Director	Buy	7,395	$1.61	$11,932.50	+292.6%	+11.2%	-15.9%
Sep 13, 2023	Clowes Howard	Director	Buy	6,993	$1.43	$10,021.67	+148.8%	+49.7%	0.0%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC